T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control

被引:150
|
作者
Warde, P
O'Sullivan, B
Bristow, RG
Panzarella, T
Keane, TJ
Gullane, PJ
Witterick, IP
Payne, D
Liu, FF
McLean, M
Waldron, J
Cummings, BJ
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M5G 2M9, Canada
关键词
glottic cancer; hemoglobin; local control; radiation therapy;
D O I
10.1016/S0360-3016(98)00062-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Pretreatment hemoglobin (Hb) level has been reported to be an important prognostic factor for local control and survival in various malignancies. However, in many settings, the adverse effect of a low Hb may be related to more advanced disease. The purpose of this analysis was to assess the influence of pretreatment Hb on local control in a large series of patients with a localized cancer (T1/T2 glottic cancer, AJCC 1992) treated in a standard fashion. Materials and Methods: Between January 1981 and December 1989, 735 patients (median age 63; 657 males, 78 females) with T1/T2 glottic cancer were treated with radiation therapy (RT). The standard RT prescription was 50 Gy in 20 fractions over 4 weeks (97% of patients). Factors studied for prognostic importance for local failure included pretreatment Hb, age, sex, T category, anterior commissure involvement, subglottic extension, and tumor bulk (presence of visible tumor vs. subclinical disease). Results: With a median follow up of 6.8 years (range 0.2-14.3), 131 patients have locally relapsed for an actuarial 5-year relapse-free rate of 81.7%. The 5-year actuarial survival was 75.8%. The mean pretreatment hemoglobin level was 14.8 g/dl and was similar in all prognostic categories. On multivariate analysis, using the Cox proportional hazards model, pretreatment Hb predicted for local failure after RT. The hazard ratio (HR) for relapse was calculated for various Hb levels. For example, the HR for a Hb of 12 g/dl vs, a Hb of 15 g/dl was 1.8 (95% confidence interval 1.2-2.5). Previously established factors, including gender, T category, subglottic extension, as well as tumor bulk, were also prognostically important for local control. Conclusions: This analysis, in a large number of similarly treated patients, indicates that pretreatment Hb is an independent prognostic factor for local control in patients with T1/T2 carcinoma of the glottis treated with RT. The underlying biology of this observation needs to be explored, and using this information, it may be possible to develop strategies to improve treatment outcome. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 50 条
  • [41] CO2 laser endoscopic resection of T1 and T2 glottic cancer:: Preliminary oncological results
    Crespo, A
    Chone, C
    Gripp, F
    Gallo, M
    Spina, A
    Altemani, A
    2ND WORLD CONGRESS OF THE INTERNATIONAL FEDERATION OF HEAD AND NECK ONCOLOGIC SOCIETIES, 2002, : 195 - 199
  • [42] BRACHYTHERAPY AND LOCAL EXCISION FOR SPHINCTER PRESERVATION IN T1 AND T2 RECTAL CANCER
    Grimard, Laval
    Stern, Hartley
    Spaans, Johanna N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (03): : 803 - 809
  • [43] The optimal radiotherapy schedule for T1 glottic cancers?
    Hendry, JH
    Slevin, NJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04): : 967 - 968
  • [44] Clinical outcomes of adjuvant radiotherapy for nodal negative T1 and T2 breast cancer
    Cetin, I. A.
    Akay, S. U.
    Ozkok, H. B. C.
    Sengoz, M.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2022, 20 (03): : 601 - 605
  • [45] Quality control in planning and technique of radiotherapy with cobalt-60 for T1 glottic cancer increase local control and organ preservation
    CortesArroyo, H
    RodriguezCuevas, S
    Labastida, S
    AMERICAN JOURNAL OF SURGERY, 1997, 174 (05): : 477 - 480
  • [46] PRETREATMENT HEMOGLOBIN LEVEL INFLUENCES LOCAL-CONTROL AND SURVIVAL OF T1-T2 SQUAMOUS-CELL CARCINOMAS OF THE GLOTTIC LARYNX
    FEIN, DA
    LEE, WR
    HANLON, AL
    RIDGE, JA
    LANGER, CJ
    CURRAN, WJ
    COIA, LR
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 2077 - 2083
  • [47] Does early glottic cancer recur early? A retrospective study of recurrence and mortality in 61 patients with T1 and T2 glottic cancers
    Liu, Alison
    Bowles, Philippe
    Walker, David
    Harries, Meredydd
    CLINICAL OTOLARYNGOLOGY, 2019, 44 (04) : 677 - 681
  • [48] Altered-Fractionation Radiotherapy Improves Local Control in T1 but Not T2 Early-Stage Glottic Carcinoma: A Systematic Review and Meta-Analysis of 1816 Patients
    Sapienza, L. G., Sr.
    Ning, M. S.
    Taguchi, S.
    Calsavara, V. F.
    Pellizon, A. C.
    Gomes, M. J. L.
    Kowalski, L. P.
    Baiocchi, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E367 - E367
  • [49] MANAGEMENT OF TIS, T1, AND T2 SQUAMOUS-CELL CARCINOMA OF THE GLOTTIC LARYNX
    MENDENHALL, WM
    PARSONS, JT
    STRINGER, SP
    CASSISI, NJ
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1994, 15 (04) : 250 - 257
  • [50] Objective voice evaluation after radiation therapy for T1 and T2 glottic tumors
    Carrara-De Angelis, E
    Santos, CR
    Cervantes, O
    Kowalski, LP
    Abrahao, M
    Fúria, C
    Brandao, AP
    Martins, N
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 341 - 343